The best of EcoWatch, right in your inbox. Sign up for our email newsletter!
Why Are Hospitals Involved in Marketing Infant Formula?
Breastfeeding has been proven to be the healthiest, most cost-effective way to feed babies. So why are hospitals helping drug and food companies market their products to exhausted new moms?
If you’ve given birth in a hospital, you may have been sent home with a complementary diaper bag or other package filled with infant formula samples, like I was. In fact, a Center for Disease Control (CDC) study shows that 66 percent of U.S. hospitals distribute them. And multiple studies have shown that women who receive them stop breastfeeding sooner than those who do not.
Food & Water Watch has joined a new effort led by Public Citizen to pressure hospitals and formula companies to stop this practice. In a letter to hospitals, a coalition of consumer and health organizations charges that they should be promoting the health of infants and mothers, not formula makers, and says that hospitals engaged in distributing free formula samples are in violation of the World Health Organization’s (WHO) International Code of Marketing of Breast-milk Substitutes, which states that healthcare facilities are not to be used for the marketing of infant formula. WHO recommends exclusively breastfeeding children up to six months of age with supplemental breastfeeding until age two.
The issue of marketing infant formula in healthcare settings is not just an issue in the U.S. One company that benefits from this hospital-assisted marketing effort is multinational Nestlé, which was a target of a highly publicized boycott in the 1970s for violating WHO guidelines on advertising, especially in developing nations. And Nestlé’s infant formula has something in common with another Nestlé product—Pure Life bottled water (which is actually just purified tap water.) What do they have in common? The company has declared them both “Popularly Positioned Products (PPPs)”. According to company documents:
PPPs target less affluent consumers in emerging markets (UN/World Bank definition—those with an annual purchasing power parity between US$3,000 and 22,000 per-capita) as well as low food spenders in developed economies. Together, they represent some 50 percent of the world’s population. Hence, PPPs target the biggest and fastest growing consumer base in emerging markets as well as important sub-groups in developed markets.
Now, Nestlé is experiencing a new wave of criticism for marketing infant formula in developing countries, where it is often prepared in unhygienic conditions with unsafe water and misunderstood directions. Laurence Gray, World Vision’s Asia-Pacific advocacy director, says of Nestlé’s tactics, “Some of the marketing strategy presents formula as better than breastfeeding. It doesn’t take into account the circumstances needed to prepare the formula.”
In an open letter to Nestlé, several Laos-based international NGOs, including Save the Children, Oxfam, CARE International, Plan International and World Vision, announced they would boycott Nestlé’s 2012 competition for a prize of almost half a million dollars for various development projects, charging that the company visits hospitals and gives doctors and nurses who promote the formula gifts and trips.
There’s another dimension to formula distribution that should give new parents pause—food safety. Recalls in recent years of formula from everything over concerns of contamination with insect parts to so-called “strange” smells reminds us that even the littlest consumers are at risk in a highly consolidated food system. The top four firms control two-thirds of the infant formula market, and contamination in one plant can be sent around the world before it’s ever detected. Most hospitals have no stock control and do not record the lot number on the bags of formula they distribute to new moms. So if a recall occurs, hospitals can’t inform parents who’ve received the samples.
Want to get involved? Sign this petition to tell formula makers to stop using hospitals as marketing tools.
For more information, click here.
EcoWatch Daily Newsletter
'We Need People's Bailout, Not Polluters' Bailout': Climate Groups Move to Preempt Big Oil Giveaway Amid Pandemic
By Andrea Germanos
A coalition of climate organizations strongly criticized President Donald Trump's in-person Friday meeting with the chief executives of some of the biggest fossil fuel companies in the world, saying the industry that fueled climate disaster must not be allowed to profiteer from government giveaways by getting bailout funds or preferred treatment during the coronavirus pandemic.
An Important Note
No supplement, diet, or lifestyle modification — aside from social distancing and practicing proper hygiene — can protect you from developing COVID-19.
The strategies outlined below may boost your immune health, but they don't protect specifically against COVID-19.
By Zak Smith
It is pretty amazing that in this moment when the COVID-19 outbreak has much of the country holed up in their homes binging Netflix, the most watched show in America over the last few weeks has been focused on wildlife trade — which scientists believe is the source of the COVID-19 pandemic. Make no mistake: Tiger King: Murder, Mayhem and Madness is about wildlife trade and other aspects of wildlife exploitation, just as surely as the appearance of Ebola, SARS, MERS, avian flu and probably COVID-19 in humans is a result of wildlife exploitation. As a conservationist, this is one of the things I've been thinking about while watching Tiger King. Here are five more:
By Hector Chapa
With the coronavirus pandemic quickly spreading, U.S. health officials have changed their advice on face masks and now recommend people wear cloth masks in public areas where social distancing can be difficult, such as grocery stores.
But can these masks be effective?
By Carey Gillam
Bayer AG is reneging on negotiated settlements with several U.S. law firms representing thousands of plaintiffs who claim exposure to Monsanto's Roundup herbicides caused them to develop non-Hodgkin lymphoma, sources involved in the litigation said on Friday.